May Health

Welcome to May Health

The Team

Colby Holtshouse

Colby Holtshouse

Chief Executive Officer
Photo of Hugh Magen

Hugh E. Magen

Chief Technical Officer
Aruna Akkapeddi headshot

Aruna Akkapeddi

Vice President, Quality Assurance/Regulatory Affairs
Connie Rey

Connie Rey

Vice President, Clinical Affairs
Photo of Cindy Domecus

Cindy Domecus

Chief Regulatory Advisor
Ross McQuivey

Ross W. McQuivey, MD

Chief Medical Advisor
Anne Bubb

Anne Bubb

Vice President, Marketing
Matt Franklin

Matt Franklin

Acting Chief Financial Officer
Join Our Team

Board of Directors

Robert Auerbach

Robert Auerbach, MD

Board Chair,
Retired President, CooperSurgical
Colby Holtshouse

Colby Holtshouse

Chief Executive Officer
Jean-Francois Morin

Jean-François Morin

Investment Director in Life Sciences, Bpifrance
Anne Osdoit

Anne Osdoit

Partner,
Sofinnova Partners
Antoine Papiernik

Antoine Papiernik

Managing Partner and Chairman,
Sofinnova Partners
Photo of Bita Sehat

Bita Sehat

Partner, Ventures, Trill Impact
Andrew Weiss

Andrew M. Weiss

Director and Venture Advisor

Investors

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management. For more information, please visit: sofinnovapartners.com.


MD Start is Sofinnova’s in-house medtech accelerator led by a team of seasoned medtech entrepreneurs and investors with extensive operational experience in high-growth early-stage medical device companies. Currently in its third iteration, MD Start has a successful track record of catalyzing innovative technology from conception to the clinic. More information: https://sofinnovapartners.com/strategy/md-start


Trill Impact is a pioneering Impact House with around EUR 1.2 billion in assets under management across its investment strategies, Impact Private Equity, Impact Ventures and Microfinance, with a team of around 55 experienced professionals based in the Nordics, Germany, Luxembourg and USA. Trill Impact aims to become a force for positive change through impact private investments, delivering Real Returns and Lasting Impact for the benefit of investors, businesses and society at large — encouraging others to follow. For more information, please visit: www.trillimpact.com


Bpifrance Investissement is the management company that handles Bpifrance’s equity investments. Bpifrance is the French national investment bank: it finances businesses — at every stage of their development — through loans, guarantees, equity investments and export insurances. Bpifrance also provides extra financial services (training, consultancy) to help entrepreneurs meet their challenges from innovation to export.For more information, please visit: www.bpifrance.com


Nexpring Health is a leading global ART solutions partner, uniting industry leaders into one powerful force dedicated to advancing fertility care. With a commitment to redefining the future of ART, Nexpring Health delivers high-quality, comprehensive ART solutions designed to simplify complexity, reduce variability, and drive consistent, confident outcomes in every cycle. Guided by core pillars of Service, Quality, Trust, and Progress, Nexpring Health ensures that embryologists, clinicians, and fertility clinics have the innovative tools and support they need, because every embryo, every procedure, and every cycle counts. Learn more at www.nexpringhealth.com


We were founded as Ziva Medical, which then integrated into Paris-based accelerator MD Start, and became Ablacare SAS and subsequently renamed to May Health SAS and May Health Inc. We’re a team of seasoned MedTech entrepreneurs with deep experience in product development, validation, and launch.

We want more for women suffering from Polycystic Ovary Syndrome (PCOS) and infertility resulting from PCOS.

chevron-down